Advertisement

Thyroid Disease in the Older Patient

  • Nages Nagaratnam
  • Kujan Nagaratnam
  • Gary Cheuk
Reference work entry

Abstract

Thyroid abnormalities are relatively common in the general population but have important clinical implications in the elderly because of the coexisting comorbidities and increased risk of heart disease and hypercholestraemia. The symptoms of thyroid diseases are more subtle in the elderly compared to younger individuals and are often attributed to normal ageing. Thyroid dysfunction is common in the elderly and is present in more than 10% of individuals over the age of 80 years and takes the form of clinical and subclinical hypo- and hyperthyroidism, nodules and thyroid cancer. The review provides an overview of thyroid disease in the elderly, prevalence and the clinical management.

Keywords

Thyroid disease in the elderly Hyperthyroidism Hypothyroidism Subclinical hypo- and hyperthyroidism Thyroid nodules Thyroid cancer 

References

  1. 1.
    Klein I, Ojamma K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001; 344:501–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Kanaya AM, Harris F, Volpato S, Perez-Stable EJ, Harris T, Bauer DC. Association between thyroid dysfunction and total cholesterol level in older bi-racial population, the health, aging and body composition study. Arch Int Med 2002;162:773–739.CrossRefGoogle Scholar
  3. 3.
    Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism : response to levothyroxine replacement, a randomize placebo-controlled study. J Clin Endocrinol Metab. 2002; 87 (4):1533–1538.CrossRefPubMedGoogle Scholar
  4. 4.
    Razvi S, Ingoe G, Keeka C, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: randomized cross over trial. J Clin Endocrinol Metab 207;92(5):1715–1723.Google Scholar
  5. 5.
    Taddei S, Caraccio A, Virdis A, Dardono A, Versar D, Ghiadoni L. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therap. J Clin Endocrinol Metab 2003;88(8):3731–3737.CrossRefPubMedGoogle Scholar
  6. 6.
    Monzani F, Caraccio M, Kozakowa M, Dadano A, Vittone F, Virdis F, et al. Effect of levothyroxine on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind placebo-controlled study. J Clin Endocrinol Metab 2004;89: 2099–206.CrossRefPubMedGoogle Scholar
  7. 7.
    Helfand M, Crapo IM. Screening for thyroid disorder. Ann Intern Med 1990; 112: 840–49.CrossRefPubMedGoogle Scholar
  8. 8.
    Boelaert K. Thyroid dysfunction in the elderly. Nature Rev Endocrinol 2013; 9:194–204.CrossRefGoogle Scholar
  9. 9.
    Chiovato L, Mariotti S, Pinchera A. Thyroid diseases in the elderly. Baillieres Clin Endocrinol Metab. 1997; 11:251–270.CrossRefPubMedGoogle Scholar
  10. 10.
    Hesch RD, Gatz J, Pape J. Total and free triiodothyronine and thyroid binding globulin concentration in elderly human persons. Eur J Clin Invest 1976;6(2):139–145.CrossRefPubMedGoogle Scholar
  11. 11.
    Jesk W, Thorner M. Serum T3 T4 and TSH in the elderly. Endokrynologia Polska. 1977; 28(2):117–123.Google Scholar
  12. 12.
    Hansen JM, Skovsted L, Nielsen KS. Age dependent changes in iodine metabolism and thyroid function. Acta Endocrinologica. 1975; 79 (1):60–65.PubMedGoogle Scholar
  13. 13.
    Hermann J, Heinen E, Kroll HJ, Rudorff KH, Kruskemper HL. Thyroid function and thyroid hormone metabolism in elderly people. Low T3 –syndrome in old age? Klin Wochenchr. 1981;59: 315–323.CrossRefGoogle Scholar
  14. 14.
    Mariotti S, Franceschi C, Cossarizza A, Pinchera A. The aging thyroid. Endocr Rev. 1995; 16:686–715.CrossRefPubMedGoogle Scholar
  15. 15.
    Begin ME, Langlois MF, Lorrain D, Cunnane SC. Thyroid function and cognition during aging. Curr Gerontol Geriatr Res. 2008; 2008 474868. https://doi.org/10.1155/2008/474868.
  16. 16.
    Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PWF, Hershman JM. Low serum thyroxine (thyroid stimulating hormone) in older persons without thyrotoxicosis. Arch Int Med. 1991;151:165–168.CrossRefGoogle Scholar
  17. 17.
    Bremner AP, Feddema P, Leedman PJ, Brown SJ, Beilby JP, Lim EM, et al. Age-related changes in thyroid function: a longitudinal study of a community –based cohort. J Clin Endocrinol Metab. 2012; 7:1554–1562.CrossRefGoogle Scholar
  18. 18.
    Tunbridge WM, Evered DC, Hall R. The spectrum of thyroid disease in a community: the Whichkham survey. Clin Endocrinol (Oxf). 1977;7: 481–93.CrossRefPubMedGoogle Scholar
  19. 19.
    Vanderpump, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid tumours in the community: a twenty year follow up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;45(1):55–68.CrossRefGoogle Scholar
  20. 20.
    Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R, et al. Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrino Invest. 2005; 28 (11):11Suppl Proceedings):101–4.Google Scholar
  21. 21.
    Shams N, Hamad S. Case:report: Hypothyroidism in the elderly. Mid East J Age Ageing. 2007;4: website: http://www.me-jaa.com/me-jaal1June07/hypothyroidism.htm.
  22. 22.
    Peeters RP. Thyroid hormones in aging. Hormones. 2008;7(1):28–35.2008.CrossRefPubMedGoogle Scholar
  23. 23.
    Goldenberg LMC. Thyroid Disease in Late Life. Thyroid Foundation of Canada. http://www.thyroid.ca/e4g.php. Retrieved 30/07/2013.
  24. 24.
    Empson M, Flood V, Ma G, Eastman CJ, Mitchell P. Prevalence of thyroid disease in older Australian population. Int Med J. 2007; 37: 448–456.CrossRefGoogle Scholar
  25. 25.
    Gesing A, Lewinski A, Karbownck-Lewinski M. The thyroid gland and the process of aging: what Is new? Thyroid Res. 2012; 5:16.  https://doi.org/10.1186/1756-6614-5-16.
  26. 26.
    Faggiono A, Del Prete M, Marciello V, Marott V, Ramundo V, Caloa, et al. Thyroid diseases in the elderly. Minerva Endocrinol. 2011; 36:211–231.Google Scholar
  27. 27.
    Rukhman N, Silverberg A. Thyroid cancer in older men. Aging Male. 2011;14: 91–98.CrossRefPubMedGoogle Scholar
  28. 28.
    Bahemuka M, Hodkinson H. Screenng for hypothyroidism in elderly patients Br Med J. 1975;2:601.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Diez JJ. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy. J Gerontol A Biol Sci Med Sci. 2002;57: M315–320. 2002.CrossRefPubMedGoogle Scholar
  30. 30.
    Almandoz JP, Gharib H. Hypothyroidism: Etiology, diagnosis and management. Med Clin N Amer. 2012; 96:203–221.CrossRefPubMedGoogle Scholar
  31. 31.
    Laurberg P, Andersen S, Bulow, Pedersen I, Carle A. Hypothyroidism in the elderly: Pathophysiology, diagnosis and treatment. Drugs Aging. 2005; 22(1): 23–38.CrossRefPubMedGoogle Scholar
  32. 32.
    Pearson T. Hypothroidism: challenges when treating older adults. J Gerontol Nursing. 2013;39(1):10–14.CrossRefGoogle Scholar
  33. 33.
    Doucet J, Trivalle C, Chassaagne P, Perol MB, Vuillermet P, Manchon ND, et al.Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc. 1994;42(9):984–6.CrossRefPubMedGoogle Scholar
  34. 34.
    Mestman J. Glob. libr.women’s med. (ISSN:1756-2228) 2008:  https://doi.org/10.3843/GLOWM.10308. Disorders of the thyroid gland.
  35. 35.
    Samuels MH. Subclinical thyroid disease in the elderly. Thyroid. 1998;8(9):803–13.CrossRefPubMedGoogle Scholar
  36. 36.
    Levy EG. Thyroid disease in the elderly. Med Clin North Am 1991;75(1):151–67.CrossRefPubMedGoogle Scholar
  37. 37.
    Toft AD. Throxine therapy. N Engl J Med. 1994;331:174–80.CrossRefPubMedGoogle Scholar
  38. 38.
    Baran DT. Thyroid hormone and bone mass.: The clinician’s dilemma. Thyroid. 1994;4:143.CrossRefPubMedGoogle Scholar
  39. 39.
    Gusssekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004;292:2591–2599.CrossRefGoogle Scholar
  40. 40.
    van den Beld AW, Visser TJ, Feelders RA, Grobbee DE, Lamberts SW. Thyroid hormone concentrations, disease, physical function and mortality in elderly men. J Clin Endocrinol Metab. 2005;90:6403–6409.CrossRefPubMedGoogle Scholar
  41. 41.
    de Luise MA. Thyroid disease in the elderly. J Pharm Pract Res.2003;33: 228–230.CrossRefGoogle Scholar
  42. 42.
    Chakera AJ, Pearce SHS, Vaidya B. Treatment of primary hypothyroidism: Current approaches and future possibilities. Drug Design Development and Therapy. 2012;6:1–11.Google Scholar
  43. 43.
    Schneider DL, Barrett-Connor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly women: Effects of oestrogen. JAMA; 1994;271: 1245–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Rosen HN, Moses AC, Gundberg C, Kung VT, Seyedin SM, Chen T, et al. Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans. J Clin Endocrinol Metab. 1993;77:664.PubMedGoogle Scholar
  45. 45.
    Nicoloff JT, Lo Presti JS. Myxedema coma. Endocrinol Metab Clin North Am. 1993;22: 279–284.PubMedGoogle Scholar
  46. 46.
    Surks MI, Oritz E, Daniels GH, Swain CT, Col NF, Cobin RH, et al. Subclinical thyroid disease; Scientific review and guidelines for the diagnosis and management. JAMA. 2004; 29(2):228–38.CrossRefGoogle Scholar
  47. 47.
    Jameson JL, Weetman AP. Disorders of the thyroid gland. In Longo, D, Fauci A, Kasper D, Haiuser S, Jameson J & Loscalzo J (Eds) Harrisons principles of Internal Medicine 18th ed pp 2911–1939. New York: McGraw–Hill. 2012.Google Scholar
  48. 48.
    Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott HT. Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association and the Endocrine Society. Thyroid. 2005;15:24–28.CrossRefPubMedGoogle Scholar
  49. 49.
    Rosenthal MJ, Hunt WC, Garry PJ, Goodwin JS. Thyroid failure in the elderly. JAMA 1987;258:209.CrossRefPubMedGoogle Scholar
  50. 50.
    Lerch M, Meier C, Staub JJ. Is there a need for treatment in subclinical hypo-hyperthyroidism? Toher Umsch 1999;56(7):369–73.CrossRefGoogle Scholar
  51. 51.
    Trivalle C, Doucet J, Chassagne P, Landrin I, Kadri N, Menard J, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996; 44(1):50–3.CrossRefPubMedGoogle Scholar
  52. 52.
    Harman SM, Wehmann RE, Balckman MR. Pituitary –thyroid hormone economy in healthy aging men. Basal indices of thyroid function and TSH responses to constant infusions of TRH. J Clin Endoc Metab. 1984;58:320–6.CrossRefGoogle Scholar
  53. 53.
    Burrows AW, Shakespeare RA, Hesch RD, Cooper E, Aickin CM, Burke CW. Thyroid hormone in the elderly sick “T4 euthyroidism”. Br Med J. 1975;4:437–9.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Peeters RP, Debaveye Y, Fliers E, Visser TJ. Changes within the thyroid axis during critical illness. Crit Care Clin. 2006;22:41–55.CrossRefPubMedGoogle Scholar
  55. 55.
    Cuellar MI. Drug-induced vasculitis. Curr Rheumatol Rep. 2002; 4:55–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Yu F, Chen M, Gao Y, et al. Clinical and pathological features of renal involvement in prophylthiouracil associated aNcA-positive vasculitis. Am J Kidney. 2007;49:607–14.CrossRefGoogle Scholar
  57. 57.
    Diez JJ. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology. 2003;49:316–323.CrossRefPubMedGoogle Scholar
  58. 58.
    Parle JV, Franklyn JA, Cross KW, Cross KW, Jones SC, Shepard MC. Thyroxine prescription in the community : serum thyroid stimulating hormone level assays as an indicator of under treatment or overtreatment. Br J Gen Pract. 1993;43:107–109.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Santos Palacios S, Pascual-Corrales E, Galofore JC. Management of subclinical hyperthyroidism. Int J Endocrinol Metab 2012;10(2):490–6.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Schliemberger MJ. Papillary and follicular carcinoma. New Engl J Med. 1998;338:297–306.CrossRefGoogle Scholar
  61. 61.
  62. 62.
    Coleman PM, Babb P, Damiecki P, Groslaude P, Honjo S, Jones J, et al. Cancer survival trends in England and Wales 1971-1995 by deprivation and NHS region (series SMPS no 61). London: Stationery Office. 1999; 471–418.Google Scholar
  63. 63.
    Girelli ME, Casara D, Rubello R, Mazzarotto R, Saladini G, Busnardo B. Differentiated thyroid cancer in the elderly, disease outcome, therapeutic approach and long term results in a group of 314 patients. J Endocrinol Invest. 1999; 22:45–46.PubMedGoogle Scholar
  64. 64.
    Lin JD, Chao TC, Chen ST, Weng HF, Lin KD. Characteristics of thyroid carcinomas in ageing patients. Eur J Clin Invest. 2000; 30:147–153.CrossRefPubMedGoogle Scholar
  65. 65.
    Health Encyclopedia-Diseases and Conditions. Thyroid Cancer. http://www.healthscout.com/ency/68/469/main.html retreived 7/21/2009.
  66. 66.
    Tan GH, Gharib H, Reading HC. Solitary thyroid nodule: Comparison between palpation and ultrasonography. Arch Intern Med. 1995;155(22):2418–2423.CrossRefPubMedGoogle Scholar
  67. 67.
    Montefiore Inspired Medicine. Thyroid Cancer. http://www.montefiore.org/thyroidcancer
  68. 68.
    Kumar V, Cotran RS, Robbins SL. Basic Pathology, fifth ed. WB Saunders Company, Philadelphia. 1992.Google Scholar
  69. 69.
    Caruso D, Mazzaferri EL. Fine needle aspiration biopsy in the management of thyroid nodules. Endocrinologist 1991;3:194.CrossRefGoogle Scholar
  70. 70.
    Ridgway EC. Clinician’s evaluation of a solitary nodule. J Clin Endocrinol Metab 1992;74:231.PubMedGoogle Scholar
  71. 71.
    Mackenzie EJ, Mortimer RH. 6.Thyroid nodules and thyroid cancer. MJA 2004;180 (5):242–247.PubMedGoogle Scholar
  72. 72.
    New York Center. Thyroid Disorders:Thyroid nodules. http://www.cumc.columbia.edu/dept/thyroid/nodules.html retreived 7?21/2009.
  73. 73.
    Beydoun MA, Beydoun HA, Kitner-Triolo MH, Kaufman JS, Evans MR, Zonderman AB. Thyroid hormone are associated with cognitive function: modulates by sex, race and depressive symptoms. J Clin Enocrinol Metab 2013; 98(8):3470–81.CrossRefGoogle Scholar
  74. 74.
    Kramer CK, Von Muhlen I, Kritz-Silverstein Y, Barrett-Connor E. Treated hypothyroidism, cognitive function and depressed mood in old age: the Rancho Bernardo Study. Eup J Endocrinol 2009; 11;917–921.CrossRefGoogle Scholar
  75. 75.
    De Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ. Endogenous subclinical thyroid disorders, physical, cognitive function, depression and mortality in older individuals. Eur J Endocrinol 2011;165(4):545–54.CrossRefPubMedGoogle Scholar
  76. 76.
    Parle J, Roberts L, Wilson S, Pattison H, Roalfe A, Haque MS, et al. A randomized controlled trial of the effect of thyroxine replacement, cognitive function in community living elderly subjects with subvclinical hypothyroidism: the Birmingham Elderly Thyroid Study. J Endocrinol Metab 2010; 95(8):3623–32.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Nages Nagaratnam
    • 1
  • Kujan Nagaratnam
    • 1
  • Gary Cheuk
    • 2
  1. 1.The University of SydneyWestmead Clinical SchoolWestmeadAustralia
  2. 2.Rehabilitation and Aged Care ServiceBlacktown-Mt Druitt HospitalMount DruittAustralia

Personalised recommendations